Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04741503 · ClinicalTrials.gov registry record · NA
Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,277
- Enrollment target
NCT04741503: Completed NA study, sponsored by Washington University School of Medicine.
NCT04741503 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,277 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04741503, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,277 participants
- Enrollment target
Study Summary
The purpose of this investigation is to conduct a feasibility study to evaluate the potential for implementing the developed decision support tool with Latina, Black, and non-Latina White women. The investigators will collect feasibility data and assess the use of the decision support tool with end-users. The aim is to determine if women using the decision support tool make more informed choices measured by knowledge, attitudes, and intentions.
Primary Outcome
* The total knowledge score will be collected by the Breast Cancer and Breast Cancer Screening Mammography knowledge questions. * This questionnaire was modified from an existing breast cancer screening knowledge from Hersch et al. This questionnaire covers mammography, screening benefits and downsides, and guidelines. * Six of the knowledge questions were scored as correct (1) or incorrect/unsure (0). The percentage of correct scores was calculated per participant pre-intervention and post-inte
Interventions
- OTHER Breast Cancer Screening Decision Support Tool
- OTHER National Cancer Institute Breast Cancer Screening PDQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,277 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2021-08-30 |
| Phase | NA |
What the finished NCT04741503 record still lists
NCT04741503 is an interventional study that assigns participants to a tested intervention. Its 1,277 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Breast Cancer Screening Decision Support Tool is the first listed.
NCT04741503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04741503 about?
NCT04741503 is a clinical study titled "Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool". The purpose of this investigation is to conduct a feasibility study to evaluate the potential for implementing the developed decision support tool with Latina, Black, and non-Latina White women. The investigators will collect feasibility data and assess the use of the decision support tool with end-...
What is the current status of trial NCT04741503?
This trial is currently completed. It is a NA study. The enrollment target is 1,277 participants. The study started on 2021-04-19. Estimated completion is 2021-08-30.
What interventions are being tested in trial NCT04741503?
The interventions under investigation include: Breast Cancer Screening Decision Support Tool (OTHER), National Cancer Institute Breast Cancer Screening PDQ (OTHER).
Who is sponsoring clinical trial NCT04741503?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04741503's enrollment target sits among peer trials
1,277 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI